Resurfacing a 2020 move: Reliance Industries acquired Netmeds in push for India’s e-pharmacy market
Reliance Industries’ August 2020 purchase of Netmeds signalled its move into online medicine delivery, as major consumer and digital players competed for scale in India’s e-pharmacy space.
What happened
Reliance Industries Ltd (RIL) · Moneycontrol explains Reliance Industries’ acquisition of Netmeds and the competitive scramble for India’s e-pharmacy market.
Why this matters
Netmeds gives Reliance an established e-pharmacy brand, customer base and healthcare supply-chain capabilities that would have taken longer to build internally.
What to watch
- Evidence of Netmeds integration into JioMart or MyJio, including shared carts, loyalty rewards or bundled delivery.
- Quarterly disclosures on digital-commerce order volumes, repeat rates, pharmacy assortment and fulfillment coverage.
- Changes in Indian central or state regulation governing online sale and delivery of prescription medicines.
- Major funding, acquisitions, pricing moves or strategic alliances involving Tata 1mg, PharmEasy, Amazon Pharmacy or large pharmacy chains.
- Launches of diagnostics, telemedicine, health subscriptions or insurer partnerships by Reliance.
- Expansion of same-day medicine delivery and store-assisted fulfillment beyond major metros.
- Integrate Netmeds ordering, payments and loyalty benefits with JioMart, MyJio and Reliance Retail channels.
- Expand private-label wellness, nutrition, personal-care and chronic-care subscription offerings alongside prescription fulfillment.
- Use Reliance Retail stores and partner pharmacies as local fulfillment, pickup and returns nodes.
- Pursue diagnostics, teleconsultation, insurance and chronic-disease management partnerships to raise basket size and engagement.
- Increase investment in prescription verification, licensed-pharmacy networks and compliance infrastructure ahead of tighter e-pharmacy rules.